BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 30586137)

  • 1. Management of Small Lung Nodules in the Era of Lung Cancer Screening.
    Berfield KS; Afolayan OA; Wood DE
    JAMA Surg; 2019 Apr; 154(4):303-304. PubMed ID: 30586137
    [No Abstract]   [Full Text] [Related]  

  • 2. Important Questions About Lung Cancer Screening Programs When Incidental Findings Exceed Lung Cancer Nodules by 40 to 1.
    Redberg RF; O'Malley PG
    JAMA Intern Med; 2017 Mar; 177(3):311-312. PubMed ID: 28135358
    [No Abstract]   [Full Text] [Related]  

  • 3. Nodule size and overdiagnosis in lung cancer CT screening.
    Vannier MW
    J Natl Cancer Inst; 2014 Nov; 106(11):. PubMed ID: 25326639
    [No Abstract]   [Full Text] [Related]  

  • 4. Assessment of indeterminate pulmonary nodules detected in lung cancer screening: Diagnostic accuracy of FDG PET/CT.
    Garcia-Velloso MJ; Bastarrika G; de-Torres JP; Lozano MD; Sanchez-Salcedo P; Sancho L; Nuñez-Cordoba JM; Campo A; Alcaide AB; Torre W; Richter JA; Zulueta JJ
    Lung Cancer; 2016 Jul; 97():81-6. PubMed ID: 27237032
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lung cancer screening: achieving more by intervening less.
    Mulshine JL; Henschke CI
    Lancet Oncol; 2014 Nov; 15(12):1284-5. PubMed ID: 25282286
    [No Abstract]   [Full Text] [Related]  

  • 6. Lung cancer screening with low-dose CT: more questions than answers.
    Ruano-Ravina A; Pérez-Ríos M
    Lancet Oncol; 2015 Jan; 16(1):e3-4. PubMed ID: 25638551
    [No Abstract]   [Full Text] [Related]  

  • 7. Ground-Glass Opacity Lung Nodules in the Era of Lung Cancer CT Screening: Radiology, Pathology, and Clinical Management.
    Pedersen JH; Saghir Z; Wille MM; Thomsen LH; Skov BG; Ashraf H
    Oncology (Williston Park); 2016 Mar; 30(3):266-74. PubMed ID: 26984222
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Should we retain smaller growing nodules in lung cancer screening programmes for surveillance?
    Ruparel M
    Thorax; 2023 May; 78(5):427-428. PubMed ID: 36697228
    [No Abstract]   [Full Text] [Related]  

  • 9. Lung cancer screening with low-dose CT: more questions than answers--author's reply.
    Mulshine JL
    Lancet Oncol; 2015 Jan; 16(1):e4. PubMed ID: 25638555
    [No Abstract]   [Full Text] [Related]  

  • 10. The Added Value of Computer-aided Detection of Small Pulmonary Nodules and Missed Lung Cancers.
    Cai J; Xu D; Liu S; Cham MD
    J Thorac Imaging; 2018 Nov; 33(6):390-395. PubMed ID: 30239461
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Persisting new nodules in incidence rounds of the NELSON CT lung cancer screening study.
    Walter JE; Heuvelmans MA; Ten Haaf K; Vliegenthart R; van der Aalst CM; Yousaf-Khan U; van Ooijen PMA; Nackaerts K; Groen HJM; De Bock GH; de Koning HJ; Oudkerk M
    Thorax; 2019 Mar; 74(3):247-253. PubMed ID: 30591535
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lessons on managing pulmonary nodules from NELSON: we have come a long way.
    Horst C; Nair A; Janes SM
    Thorax; 2019 May; 74(5):427-429. PubMed ID: 30842256
    [No Abstract]   [Full Text] [Related]  

  • 13. Occurrence and lung cancer probability of new solid nodules at incidence screening with low-dose CT: analysis of data from the randomised, controlled NELSON trial.
    Walter JE; Heuvelmans MA; de Jong PA; Vliegenthart R; van Ooijen PMA; Peters RB; Ten Haaf K; Yousaf-Khan U; van der Aalst CM; de Bock GH; Mali W; Groen HJM; de Koning HJ; Oudkerk M
    Lancet Oncol; 2016 Jul; 17(7):907-916. PubMed ID: 27283862
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Localized thin-section CT with radiomics feature extraction and machine learning to classify early-detected pulmonary nodules from lung cancer screening.
    Tu SJ; Wang CW; Pan KT; Wu YC; Wu CT
    Phys Med Biol; 2018 Mar; 63(6):065005. PubMed ID: 29446758
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relationship between the number of new nodules and lung cancer probability in incidence screening rounds of CT lung cancer screening: The NELSON study.
    Walter JE; Heuvelmans MA; de Bock GH; Yousaf-Khan U; Groen HJM; van der Aalst CM; Nackaerts K; van Ooijen PMA; de Koning HJ; Vliegenthart R; Oudkerk M
    Lung Cancer; 2018 Nov; 125():103-108. PubMed ID: 30429006
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Indeterminate pulmonary nodules: risk for having or for developing lung cancer?
    Massion PP; Walker RC
    Cancer Prev Res (Phila); 2014 Dec; 7(12):1173-8. PubMed ID: 25348855
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Diffuse idiopathic pulmonary neuroendocrine cell hyperplasia: Usefulness of espiratory chest CT].
    Farfán Leal F; Silva Rodríguez Á; Gorospe Sarasúa L
    Med Clin (Barc); 2016 Jul; 147(1):e3-4. PubMed ID: 26971982
    [No Abstract]   [Full Text] [Related]  

  • 18. Lung cancer risk in new pulmonary nodules: implications for CT screening and nodule management.
    Baldwin DR; Devaraj A
    Lancet Oncol; 2016 Jul; 17(7):849-850. PubMed ID: 27283864
    [No Abstract]   [Full Text] [Related]  

  • 19. A review of lung cancer screening and the role of computer-aided detection.
    Al Mohammad B; Brennan PC; Mello-Thoms C
    Clin Radiol; 2017 Jun; 72(6):433-442. PubMed ID: 28185635
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lung cancer CT screening: Psychological responses in the presence and absence of pulmonary nodules.
    Clark ME; Bedford LE; Young B; Robertson JFR; das Nair R; Vedhara K; Littleford R; Sullivan FM; Mair FS; Schembri S; Rauchhaus P; Kendrick D
    Lung Cancer; 2018 Oct; 124():160-167. PubMed ID: 30268456
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.